Advertisement

Topics

New products boost Q3 sales at GSK

03:45 EDT 26 Oct 2017 | PharmaTimes

GlaxoSmithKline has posted a near 4 percent rise in sales for the third quarter of the year, driven by a solid performance by its HIV and respiratory therapies and a weak pound.

Original Article: New products boost Q3 sales at GSK

NEXT ARTICLE

More From BioPortfolio on "New products boost Q3 sales at GSK"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

AIDS and HIV
AIDS; Acquired Immune Deficiency Syndrome. HIV; Human Immunodeficiency Virus HIV infection causes AIDS. HIV infection also causes the production of anti-HIV antibodies, which forms the test for HIV in patients. People who have the HIV antibodies are ...

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...